Subcutaneous adipose tissue insulin resistance and lipolysis in patients with nonalcoholic steatohepatitis
Päätekijät: | Armstrong, M, Hazlehurst, J, Hull, D, Borrows, S, Guo, K, Yu, J, Barton, D, Gaunt, P, Gough, S, Tomlinson, J, Newsome, P |
---|---|
Aineistotyyppi: | Conference item |
Julkaistu: |
2013
|
Samankaltaisia teoksia
-
Abdominal subcutaneous adipose tissue insulin resistance and lipolysis in patients with non-alcoholic steatohepatitis
Tekijä: Armstrong, M, et al.
Julkaistu: (2014) -
Abdominal subcutaneous adipose tissue insulin resistance and lipolysis in patients with non-alcoholic steatohepatitis.
Tekijä: Armstrong, M, et al.
Julkaistu: (2014) -
Glucagon like peptide 1 analogue, Liraglutide, reduces adipose insulin resistance and hepatic de novo lipogenesis in Nonalcoholic Steatohepatitis: Sub-study results of a phase II randomised-control clinical trial
Tekijä: Armstrong, M, et al.
Julkaistu: (2013) -
Glucocorticoids fail to cause insulin resistance in human subcutaneous adipose tissue in vivo.
Tekijä: Hazlehurst, J, et al.
Julkaistu: (2013) -
Orlistat for overweight subjects with nonalcoholic steatohepatitis.
Tekijä: Dowman, J, et al.
Julkaistu: (2009)